- Home
- YCBD vs AMST Comparison
YCBD vs AMST Comparison
Compare YCBD & AMST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | YCBD | AMST |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0M | 6.1M |
| IPO Year | 2018 | 2020 |
Fundamental Metrics
Financial Performance| Metric | YCBD | AMST |
|---|---|---|
| Price | $0.37 | $0.63 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 87.1K | 74.4K |
| Earning Date | 08-13-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 39.11 | 38.83 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $19,190,468.00 | $364,777.00 |
| Revenue This Year | $14.24 | $19,089.81 |
| Revenue Next Year | $30.43 | $22.86 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 230.24 |
| 52 Week Low | $0.33 | $0.63 |
| 52 Week High | $2.56 | $3.90 |
Technical Indicators
Market Signals| Indicator | YCBD | AMST |
|---|---|---|
| Relative Strength Index (RSI) | 39.03 | 18.08 |
| Support Level | $0.33 | N/A |
| Resistance Level | $0.53 | $1.11 |
| Average True Range (ATR) | 0.03 | 0.05 |
| MACD | 0.00 | -0.03 |
| Stochastic Oscillator | 35.14 | 0.03 |
Price Performance
Historical ComparisonAbout YCBD cbdMD Inc.
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.
About AMST Amesite Inc.
Amesite Inc is a technology company focused on building and commercializing AI (artificial intelligence)-powered solutions for the enterprise and for professionals, with particular emphasis on the post-acute healthcare market. It operates through two product lines: NurseMagic and LynkMagic. NurseMagic solutions include a B2B (business-to-business) enterprise application and a B2C (business-to-consumer) solution for individual healthcare professionals. LynkMagic provides enterprise AI solutions for healthcare and related organizations. Its products support documentation, workflow, compliance, oversight, and are designed to improve operational quality and efficiency. It has one single operating and reporting segment, B2C and B2B AI-driven solutions.